Tuesday, 20. March 2018 - 12:26GenomicsGenomics England extends access to datasets for researchers More than 500 researchers will be able to access the 100,000 Genomes Project datasetFeatured Article: 0
Meet Michael Seres - part of our ELS London AI debate
HIMSS UK 15.03.18
AI-enabled healthcare - potential and challenges. Are we ready? Join the debate.
We are thrilled that Michael Seres is going to be joing our panel discussion around AI at the Executive Leadership Summit in London on March 22nd.
Michael is the founder of 11Health, the world’s first sensor network company focused on helping patients with long term chronic conditions who are connected to medical bags. He was diagnosed aged 12 with the incurable bowel condition Crohn's Disease. In late 2011 he became the 11th person to undergo a small bowel transplant in the UK at The Churchill Hospital in Oxford. More recently he is a two time cancer survivor.
Michael started blogging about his journey and is a published author and patient mentor. He was the co-Chair of NHS Digital Services User Council & helped implement the first skype clinics in UK. In 2015 he was announced as Stanford Medicine X first Patient-in-Residence and is an Executive Board member.
The debate will consider:
• The legal status of a decision made by an autonomous system
• Who is accountable for the decision it makes?
• The ethics of trying to codify the complex tradeoffs that occur every day in healthcare
• The confidence of the public and professional in AI with its ‘black box’ image and the notion of loss of human control
This session will be chaired by Dr Mark Davies, Chief Medical Officer, HIMSS UK
Haven't registered your place yet? Request in invitation now!